Concord Biotech Ltd Declares Q1 FY27 Unaudited Financial Results

Concord Biotech Limited announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The Board of Directors, following a review by the Audit Committee, approved these results. The company submitted the results along with a Limited Review Report from its statutory auditors, BSR & Co. LLP, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3:30 PM and concluded at 4:35 PM on July 31, 2026. The limited review report indicates no material misstatements were found in the accompanying financial statements.